Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

211 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Detection of KRAS and BRAF mutations in colorectal carcinoma roles for high-sensitivity locked nucleic acid-PCR sequencing and broad-spectrum mass spectrometry genotyping.
Arcila M, Lau C, Nafa K, Ladanyi M. Arcila M, et al. J Mol Diagn. 2011 Jan;13(1):64-73. doi: 10.1016/j.jmoldx.2010.11.005. Epub 2010 Dec 23. J Mol Diagn. 2011. PMID: 21227396 Free PMC article.
Synchronous follicular lymphoma, kaposi sarcoma, and castleman's disease in a HIV-negative patient with EBV and HHV-8 coinfection.
Koreishi AF, Saenz AJ, Arcila ME, Hedvat C, Fleming S, Teruya-Feldstein J. Koreishi AF, et al. Among authors: arcila me. Int J Surg Pathol. 2011 Oct;19(5):685-91. doi: 10.1177/1066896909341803. Epub 2009 Aug 5. Int J Surg Pathol. 2011. PMID: 19661098
High expression levels of total IGF-1R and sensitivity of NSCLC cells in vitro to an anti-IGF-1R antibody (R1507).
Gong Y, Yao E, Shen R, Goel A, Arcila M, Teruya-Feldstein J, Zakowski MF, Frankel S, Peifer M, Thomas RK, Ladanyi M, Pao W. Gong Y, et al. Among authors: arcila m. PLoS One. 2009 Oct 6;4(10):e7273. doi: 10.1371/journal.pone.0007273. PLoS One. 2009. PMID: 19806209 Free PMC article.
Assessment of EGFR mutation status in lung adenocarcinoma by immunohistochemistry using antibodies specific to the two major forms of mutant EGFR.
Brevet M, Arcila M, Ladanyi M. Brevet M, et al. Among authors: arcila m. J Mol Diagn. 2010 Mar;12(2):169-76. doi: 10.2353/jmoldx.2010.090140. Epub 2010 Jan 21. J Mol Diagn. 2010. PMID: 20093391 Free PMC article.
Phase II trial of gefitinib and everolimus in advanced non-small cell lung cancer.
Price KA, Azzoli CG, Krug LM, Pietanza MC, Rizvi NA, Pao W, Kris MG, Riely GJ, Heelan RT, Arcila ME, Miller VA. Price KA, et al. Among authors: arcila me. J Thorac Oncol. 2010 Oct;5(10):1623-9. doi: 10.1097/JTO.0b013e3181ec1531. J Thorac Oncol. 2010. PMID: 20871262 Free PMC article. Clinical Trial.
Acquired resistance to EGFR tyrosine kinase inhibitors in EGFR-mutant lung cancer: distinct natural history of patients with tumors harboring the T790M mutation.
Oxnard GR, Arcila ME, Sima CS, Riely GJ, Chmielecki J, Kris MG, Pao W, Ladanyi M, Miller VA. Oxnard GR, et al. Among authors: arcila me. Clin Cancer Res. 2011 Mar 15;17(6):1616-22. doi: 10.1158/1078-0432.CCR-10-2692. Epub 2010 Dec 6. Clin Cancer Res. 2011. PMID: 21135146 Free PMC article. Clinical Trial.
Rebiopsy of lung cancer patients with acquired resistance to EGFR inhibitors and enhanced detection of the T790M mutation using a locked nucleic acid-based assay.
Arcila ME, Oxnard GR, Nafa K, Riely GJ, Solomon SB, Zakowski MF, Kris MG, Pao W, Miller VA, Ladanyi M. Arcila ME, et al. Clin Cancer Res. 2011 Mar 1;17(5):1169-80. doi: 10.1158/1078-0432.CCR-10-2277. Epub 2011 Jan 19. Clin Cancer Res. 2011. PMID: 21248300 Free PMC article.
Clinical characteristics of patients with lung adenocarcinomas harboring BRAF mutations.
Paik PK, Arcila ME, Fara M, Sima CS, Miller VA, Kris MG, Ladanyi M, Riely GJ. Paik PK, et al. Among authors: arcila me. J Clin Oncol. 2011 May 20;29(15):2046-51. doi: 10.1200/JCO.2010.33.1280. Epub 2011 Apr 11. J Clin Oncol. 2011. PMID: 21483012 Free PMC article.
Maintained sensitivity to EGFR tyrosine kinase inhibitors in EGFR-mutant lung cancer recurring after adjuvant erlotinib or gefitinib.
Oxnard GR, Janjigian YY, Arcila ME, Sima CS, Kass SL, Riely GJ, Pao W, Kris MG, Ladanyi M, Azzoli CG, Miller VA. Oxnard GR, et al. Among authors: arcila me. Clin Cancer Res. 2011 Oct 1;17(19):6322-8. doi: 10.1158/1078-0432.CCR-11-1080. Epub 2011 Aug 10. Clin Cancer Res. 2011. PMID: 21831955 Free PMC article.
Coexistence of PIK3CA and other oncogene mutations in lung adenocarcinoma-rationale for comprehensive mutation profiling.
Chaft JE, Arcila ME, Paik PK, Lau C, Riely GJ, Pietanza MC, Zakowski MF, Rusch V, Sima CS, Ladanyi M, Kris MG. Chaft JE, et al. Among authors: arcila me. Mol Cancer Ther. 2012 Feb;11(2):485-91. doi: 10.1158/1535-7163.MCT-11-0692. Epub 2011 Dec 1. Mol Cancer Ther. 2012. PMID: 22135231 Free PMC article.
211 results
Jump to page
Feedback